Search

everythinglearnresearchcommunity

for

Search:↓

Spinach-derived thylakoid supplements plus a low-calorie diet helped obese women with polycystic ovary syndrome lose weight and improve their metabolism.

Women with PCOS have more depression and stress due to high androgen levels, not obesity or insulin resistance.

The free androgen index varies among women with different types of PCOS.

The IRS-2 Asp/Asp genotype may increase the risk of PCOS in Chinese women, especially if they are not obese.

Combining letrozole with metformin is the most effective treatment for inducing pregnancy in women with PCOS.

Medications for PCOS don't seem to raise heart disease risk.

Polycystic Ovary Syndrome (PCOS) in teenagers is a complex condition linked to genetics and environment, often associated with obesity and insulin resistance, and is treated with lifestyle changes and medication.

Brown Adipose Tissue (BAT) could potentially treat Polycystic Ovary Syndrome (PCOS) by controlling energy balance and lipid homeostasis, but more human research is needed.

Certain gene variants may contribute to high androgen levels in women with polycystic ovary syndrome.

Women with PCOS who have high male hormone levels often also have insulin resistance.

Women with PCOS have similar bone density to healthy women, but those who are obese have higher bone density at some body sites.

Excess male hormones in postmenopausal women can cause health issues and increase the risk of heart disease and diabetes; treatment depends on the cause.

Women with PCOS have higher levels of AMH in their blood and follicles, and this can help predict their risk of overreaction to fertility treatments.

Women with PCOS often have irregular periods, a higher chance of infertility and miscarriages, and may improve fertility with lifestyle changes and treatment.

Adding anti-Müllerian hormone to PCOS criteria lowers the number of women diagnosed.

Women with PCOS may have a higher risk of respiratory and ear infections due to slower nasal mucociliary clearance.

The VEGF +405G allele may increase the risk of PCOS in South Indian women.

Women with PCOS have a higher chance of experiencing depression, anxiety, and sleep disorders.

PCOS affects about 4% of women in the southeastern U.S. equally across Black and White populations.

A new mutation in the CYP11B1 gene was found in a woman with mild hyperandrogenemia, a rare cause of non-classic congenital adrenal hyperplasia.

Sexual orientation does not affect the prevalence of PCOS or fertility rates in women undergoing artificial donor insemination.

South Asian women with PCOS experience more psychological distress and have a poorer quality of life, especially in social relationships, with hirsutism affecting them more than obesity.

Over a third of women thought to have non-classical congenital adrenal hyperplasia didn't have it confirmed by genetic tests.

The conclusion is that PCOS is caused by ovarian sensitivity to hormones and disrupted hormone control, possibly due to ovarian factors, and more research is needed.

The document concludes that identifying the cause of amenorrhea is crucial for proper treatment.

Insulin resistance is linked to PCOS and can lead to other health issues, but treatments like metformin can help manage symptoms.

About 3% of high school girls aged 14-18 in Isfahan, Iran, have polycystic ovary syndrome.

Hair loss in middle-aged women is often linked to insulin resistance and a family history of hair loss, particularly from their fathers.

About 6.5% of young Caucasian women in Spain have polycystic ovary syndrome.

Female Pattern Hair Loss affects women's self-esteem and needs more research for better treatment.